The AIRLYMPUS Study is testing an investigational study drug to see if it is safe and can possibly improve breathing and symptoms of asthma and potentially reduce future asthma attacks when taken with standard asthma background therapy.
Your participation is voluntary. By participating, you could possibly contribute to the discovery of a potential future new treatment for people like you who have asthma.
Contact us to complete the survey and find out in minutes if you're qualified. (281) 377-3988 or houston@axsendoclinical.com
Asthma can cause shortness of breath and wheezing that limits your ability to keep up with work, family, and friends.
Asthma can also lead to fatigue and low energy, making it harder to engage in normal daily activities.
Whether it’s missing out on social activities, avoiding physical exercise, struggling to keep up at work or school, or constantly worrying about when the next flare-up will strike, asthma can quietly limit the freedom to live life to the fullest.
This clinical study is being offered in our Houston, Texas market and is investigating a potential treatment that may help reduce some symptoms of asthma. To find out how you may be able to participate, click the button below.
If you qualify for the study, you will receive either the investigational study drug
or the placebo. Treatment, tests, and doctor visits at no cost to you.
You may be in the study for up to 64 weeks.
Adults between the ages of 18 and 80
Have had a diagnosis of asthma within the past 12 months
Have had at least 1 asthma attack in the last year and currently taking treatment for your daily asthma